Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

BACKGROUND: We evaluated the efficacy and safety of single-dose fosaprepitant in combination with intravenous granisetron and dexamethasone. PATIENTS AND METHODS: Patients receiving chemotherapy including cisplatin (≥70 mg/m(2)) were eligible. A total of 347 patients (21% had received cisplatin with...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, H., Yoshizawa, H., Yoshimori, K., Katakami, N., Katsumata, N., Kawahara, M., Eguchi, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603438/
https://www.ncbi.nlm.nih.gov/pubmed/23117073
http://dx.doi.org/10.1093/annonc/mds541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603438/
https://www.ncbi.nlm.nih.gov/pubmed/23117073
http://dx.doi.org/10.1093/annonc/mds541

Ejemplares similares